Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on?
Pediatric patients receiving conventional chemotherapy for malignant disease face an increased risk of bloodstream infection (BSI). Since BSI may represent an acute life-threatening event in patients with profound immunosuppression, and show further negative impact on quality of life and anticancer...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
German Medical Science GMS Publishing House
2016-05-01
|
| Series: | GMS Hygiene and Infection Control |
| Subjects: | |
| Online Access: | http://www.egms.de/static/en/journals/dgkh/2016-11/dgkh000271.shtml |
| _version_ | 1818384251650834432 |
|---|---|
| author | Simon, Arne Furtwängler, Rhoikos Graf, Norbert Laws, Hans Jürgen Voigt, Sebastian Piening, Brar Geffers, Christine Agyeman, Philipp Ammann, Roland A. |
| author_facet | Simon, Arne Furtwängler, Rhoikos Graf, Norbert Laws, Hans Jürgen Voigt, Sebastian Piening, Brar Geffers, Christine Agyeman, Philipp Ammann, Roland A. |
| author_sort | Simon, Arne |
| collection | DOAJ |
| description | Pediatric patients receiving conventional chemotherapy for malignant disease face an increased risk of bloodstream infection (BSI). Since BSI may represent an acute life-threatening event in patients with profound immunosuppression, and show further negative impact on quality of life and anticancer treatment, the prevention of BSI is of paramount importance to improve and guarantee patients’ safety during intensive treatment. The great majority of all pediatric cancer patients (about 85%) have a long-term central venous access catheter in use (type Broviac or Port; CVAD). Referring to the current surveillance definitions a significant proportion of all BSI in pediatric patients with febrile neutropenia is categorized as CVAD- BSI. This state of the art review summarizes the epidemiology and the distinct pathogen profile of BSI in pediatric cancer patients from the perspective of infection surveillance. Problems in executing the current surveillance definition in this patient population are discussed and a new concept for the surveillance of BSI in pediatric cancer patients is outlined. |
| first_indexed | 2024-12-14T03:19:18Z |
| format | Article |
| id | doaj.art-05c7a3beb63b4dd78b529dab74d2fbfb |
| institution | Directory Open Access Journal |
| issn | 2196-5226 |
| language | deu |
| last_indexed | 2024-12-14T03:19:18Z |
| publishDate | 2016-05-01 |
| publisher | German Medical Science GMS Publishing House |
| record_format | Article |
| series | GMS Hygiene and Infection Control |
| spelling | doaj.art-05c7a3beb63b4dd78b529dab74d2fbfb2022-12-21T23:19:04ZdeuGerman Medical Science GMS Publishing HouseGMS Hygiene and Infection Control2196-52262016-05-0111Doc1110.3205/dgkh000271Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on?Simon, Arne0Furtwängler, Rhoikos1Graf, Norbert2Laws, Hans Jürgen3Voigt, Sebastian4Piening, Brar5Geffers, Christine6Agyeman, Philipp7Ammann, Roland A.8Pädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg, GermanyPädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg, GermanyPädiatrische Onkologie und Hämatologie, Universitätsklinikum des Saarlandes, Homburg, GermanyKlinik für Pädiatrische Onkologie, Hämatologie und Immunologie, Universitätskinderklinik, Heinrich-Heine-Universität, Düsseldorf, GermanyKlinik für Pädiatrie m. S. Onkologie / Hämatologie / Stammzelltransplantation, Charité – Universitätsmedizin Berlin, GermanyInstitut für Hygiene und Umweltmedizin, Charité – Universitätsmedizin Berlin, GermanyInstitut für Hygiene und Umweltmedizin, Charité – Universitätsmedizin Berlin, GermanyPädiatrische Infektiologie und Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinderheilkunde, Inselspital, Bern, SwitzerlandPädiatrische Infektiologie und Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinderheilkunde, Inselspital, Bern, SwitzerlandPediatric patients receiving conventional chemotherapy for malignant disease face an increased risk of bloodstream infection (BSI). Since BSI may represent an acute life-threatening event in patients with profound immunosuppression, and show further negative impact on quality of life and anticancer treatment, the prevention of BSI is of paramount importance to improve and guarantee patients’ safety during intensive treatment. The great majority of all pediatric cancer patients (about 85%) have a long-term central venous access catheter in use (type Broviac or Port; CVAD). Referring to the current surveillance definitions a significant proportion of all BSI in pediatric patients with febrile neutropenia is categorized as CVAD- BSI. This state of the art review summarizes the epidemiology and the distinct pathogen profile of BSI in pediatric cancer patients from the perspective of infection surveillance. Problems in executing the current surveillance definition in this patient population are discussed and a new concept for the surveillance of BSI in pediatric cancer patients is outlined.http://www.egms.de/static/en/journals/dgkh/2016-11/dgkh000271.shtmlpediatric oncologybloodstream infectionBroviacPortsurveillance |
| spellingShingle | Simon, Arne Furtwängler, Rhoikos Graf, Norbert Laws, Hans Jürgen Voigt, Sebastian Piening, Brar Geffers, Christine Agyeman, Philipp Ammann, Roland A. Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? GMS Hygiene and Infection Control pediatric oncology bloodstream infection Broviac Port surveillance |
| title | Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? |
| title_full | Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? |
| title_fullStr | Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? |
| title_full_unstemmed | Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? |
| title_short | Surveillance of bloodstream infections in pediatric cancer centers – what have we learned and how do we move on? |
| title_sort | surveillance of bloodstream infections in pediatric cancer centers what have we learned and how do we move on |
| topic | pediatric oncology bloodstream infection Broviac Port surveillance |
| url | http://www.egms.de/static/en/journals/dgkh/2016-11/dgkh000271.shtml |
| work_keys_str_mv | AT simonarne surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT furtwanglerrhoikos surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT grafnorbert surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT lawshansjurgen surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT voigtsebastian surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT pieningbrar surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT gefferschristine surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT agyemanphilipp surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon AT ammannrolanda surveillanceofbloodstreaminfectionsinpediatriccancercenterswhathavewelearnedandhowdowemoveon |